Evidence map›Paper›PMID 36109184›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

PET Imaging of Neutrophil Elastase with

Emmi Puuvuori, Elena Chiodaroli, Sergio Estrada, Pierre Cheung, Norbert Lubenow, Jonathan Sigfridsson, Hampus Romelin, Sofie Ingvast, Mathias Elgland, Francesco Liggieri and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Emmi PuuvuoriScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Elena ChiodaroliHedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala Sweden.
Sergio EstradaScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Pierre CheungScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Norbert LubenowDepartment of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden; and.
Jonathan SigfridssonPET Center, Center for Medical Imaging, Uppsala University Hospital, Uppsala, Sweden.
Hampus RomelinPET Center, Center for Medical Imaging, Uppsala University Hospital, Uppsala, Sweden.
Sofie IngvastDepartment of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden; and.
Mathias ElglandScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Francesco LiggieriHedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala Sweden.
Olle KorsgrenDepartment of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden; and.
Gaetano PerchiazziHedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala Sweden.
Olof ErikssonScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden; olof.eriksson@ilk.uu.se gunnar.antoni@akademiska.se.
Gunnar AntoniScience for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden; olof.eriksson@ilk.uu.se gunnar.antoni@akademiska.se.
Uppsala University · SEScience for Life Laboratory · SEUppsala University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today, there is a lack of clinically available imaging techniques to detect and quantify specific immune cell populations. Neutrophils are one of the first immune cells at the site of inflammation, and they secrete the serine protease neutrophil elastase (NE), which is crucial in the fight against pathogens. However, the prolonged lifespan of neutrophils increases the risk that patients will develop severe complications, such as acute respiratory distress syndrome (ARDS). Here, we evaluated the novel radiolabeled NE inhibitor

Indexed as

Leukocyte ElastaseRespiratory Distress SyndromeAnimalsInflammationNeutrophilsOleic AcidPositron Emission Tomography Computed TomographySwineLeukocyte ElastaseOleic AcidARDSinflammationneutrophil elastasePET

Identifiers

PMID36109184
PMCPMC10071803
OpenAlexW4296032641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.